Acute renal failure and liver dysfunction after subcutaneous injection of 3-sn-phosphatidylcholine (Lipostabil®) - Case report;Akutes Nierenversagen und Lebersynthesestörung nach subkutaner Injektion von 3-sn-Phosphatidylcholin (Lipostabil®)

Zeitschrift fur Gastroenterologie

Volumn 49, Issue 3, 2011, Pages 340-343

  Rey, J W ^a   Schreiner, O ^a   Barreiros, A P ^a   Heise, M ^a   Krupp, M ^a   Schuchmann, M ^a   Otto, G ^a   Galle, P R ^a   Teufel, A ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

acute renal failure; aesthetic therapy; haemodialysis; Lipostabil; liver dysfunction; phosphatidylcholine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CREATININE; LACTULOSE; LIPOSTABIL; VITAMIN K GROUP;

ACUTE KIDNEY FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANURIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING TEST; BLOOD CULTURE; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; FAT EMBOLISM; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERKALEMIA; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIVER DYSFUNCTION; NAUSEA AND VOMITING; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PROTEINURIA; RISK FACTOR; SEPTIC SHOCK;

ACUTE KIDNEY INJURY; ADULT; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; NEPHRITIS; PHOSPHATIDYLCHOLINES;

EID: 79952515742     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1245614     Document Type: Article

References (12)

1. Lieber S et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994 106 152-159
2. Rotunda A M. et al. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 2004 30 1001-1008 (Pubitemid 38890909)
3. Salti G et al. Phosphatidylcholine and sodium deoxycholate in the treatment of localized fat: a double-blind, randomized study. Dermatol Surg 2008 34 60-66; discussion 66 (Pubitemid 350308587)
4. Klein S M. et al. In vitro studies investigating the effect of subcutaneous phosphatidylcholine injections in the 3T3-L1 adipocyte model: lipolysis or lipid dissolution? Plast Reconstr Surg 2009 124 419-427
5. Palmer M, Curran J, Bowler P. Clinical experience and safety using phosphatidylcholine injections for the localized reduction of subcutaneous fat: a multicentre, retrospective UK study. J Cosmet Dermatol 2006 5 218-226 (Pubitemid 44314383)
6. Duncan D I., Hasengschwandtner F. Lipodissolve for subcutaneous fat reduction and skin retraction. Aesthet Surg J 2005 25 530-543 (Pubitemid 41574461)
7. Bechara F G. et al. Fat tissue after lipolysis of lipomas: a histopathological and immunohistochemical study. J Cutan Pathol 2007 34 552-557 (Pubitemid 46920255)
8. Rittes P G., Rittes J C., Carriel Amary M F. Injection of phosphatidylcholine in fat tissue: experimental study of local action in rabbits. Aesthetic Plast Surg 2006 30 474-478 (Pubitemid 44198088)
9. Schuller-Petrovic S et al. Tissue-toxic effects of phosphatidylcholine/ deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteer. Dermatol Surg 2008 34 529-542; discussion 542 - 543 (Pubitemid 351442712)
10. Janke J et al. Compounds used for injection lipolysis' destroy adipocytes and other cells found in adipose tissue. Obes Facts 2009 2 36-39
11. Rittes P G. Complications of Lipostabil Endovena for treating localized fat deposits. Aesthet Surg J 2007 27 146-149 (Pubitemid 46561939)
12. Hexsel D et al. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2003 2 511-518